SG Americas Securities’s PhenomeX Inc. Common Stock CELL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-45,387
Closed -$22K 3308
2023
Q2
$22K Sell
45,387
-37,925
-46% -$31K ﹤0.01% 2174
2023
Q1
$97K Sell
83,312
-3,305
-4% -$6.04K ﹤0.01% 2928
2022
Q4
$232K Sell
86,617
-36,044
-29% -$95K ﹤0.01% 2097
2022
Q3
$351K Sell
122,661
-29,785
-20% -$127K ﹤0.01% 1857
2022
Q2
$758K Buy
152,446
+63,455
+71% +$332K 0.01% 1567
2022
Q1
$633K Buy
88,991
+57,703
+184% +$477K ﹤0.01% 1738
2021
Q4
$569K Buy
31,288
+14,486
+86% +$313K ﹤0.01% 2083
2021
Q3
$329K Buy
+16,802
New +$639K ﹤0.01% 2860

Other funds holding CELL

SG Americas Securities's CELL Position: Q3 2023 in Review

SG Americas Securities sold out of PhenomeX Inc. Common Stock (CELL) in Q3 2023, closing a stake of 45,387 shares — an estimated $22K sold.

SG Americas Securities first reported a position in CELL in Q3 2021 and held it in 8 quarters. The position peaked at $758K in Q2 2022. 57 funds tracked by Wall St. Rank hold CELL as of Q3 2023.

  • SG Americas Securities reported no remaining PhenomeX Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
  • SG Americas Securities sold 45,387 PhenomeX Inc. Common Stock shares in Q3 2023, an estimated $22K.
  • SG Americas Securities first reported a position in PhenomeX Inc. Common Stock in Q3 2021 and held it in 8 quarters.
  • SG Americas Securities's PhenomeX Inc. Common Stock position peaked at $758K in Q2 2022.
  • 57 funds tracked by Wall St. Rank held PhenomeX Inc. Common Stock as of Q3 2023.

Based on SG Americas Securities's 13F filing for Q3 2023, filed 13 Oct 2023.